Microbiology testing associated with antibiotic dispensing in older community-dwelling adults
Open Access
- 25 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12879-020-05029-z
Abstract
It is commonly recommended that microbiological assessment should accompany the use of antibiotics prone to resistance. We sought to estimate the rate of microbiology testing and compare this to dispensing of the World Health Organization classified “watch” group antibiotics in primary care. Data from a cohort of older adults (mean age 69 years) were linked to Australian national health insurance (Pharmaceutical Benefits Scheme & Medicare Benefits Schedule) records of community-based antibiotic dispensing and microbiology testing in 2015. Participant characteristics associated with greater watch group antibiotic dispensing and microbiology testing were estimated using adjusted incidence rate ratios (aIRR) and 95% confidence intervals (CI) in multivariable zero-inflated negative binomial regression models. In 2015, among 244,299 participants, there were 63,306 watch group antibiotic prescriptions dispensed and 149,182 microbiology tests conducted; the incidence rate was 0.26 per person-year for watch group antibiotic dispensing and 0.62 for microbiology testing. Of those antibiotic prescriptions, only 19% were accompanied by microbiology testing within − 14 to + 7 days. After adjusting for socio-demographic factors and co-morbidities, individuals with chronic respiratory diseases were more likely to receive watch group antibiotics than those without, e.g. asthma (aIRR:1.59, 95%CI:1.52–1.66) and chronic obstructive pulmonary disease (COPD) (aIRR:2.71, 95%CI:2.48–2.95). However, the rate of microbiology testing was not comparably higher among them (with asthma aIRR:1.03, 95%CI:1.00–1.05; with COPD aIRR:1.00, 95%CI:0.94–1.06). Priority antibiotics with high resistance risk are commonly dispensed among community-dwelling older adults. The discord between the rate of microbiology testing and antibiotic dispensing in adults with chronic respiratory diseases suggests the potential for excessive empirical prescribing.Funding Information
- Australian National Health and Medical Research Council (1048180)
This publication has 27 references indexed in Scilit:
- Quality Indicators to Measure Appropriate Antibiotic Use in Hospitalized AdultsClinical Infectious Diseases, 2014
- Quantifying under-reporting of pathology tests in Medical Benefits Schedule claims dataAustralian Health Review, 2013
- Executive Summary: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2012
- Seasonality and Temporal Correlation between Community Antibiotic Use and Resistance in the United StatesClinical Infectious Diseases, 2012
- Inappropriate Use of Antibiotics for Acute Asthma in United States Emergency DepartmentsAcademic Emergency Medicine, 2008
- The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospitalClinical Microbiology & Infection, 2008
- Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programmeThe Lancet Infectious Diseases, 2008
- Cohort Profile: The 45 and Up StudyInternational Journal of Epidemiology, 2007
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005